EGFR and cancer: Maolan et al. (24) analyzed the exon sequencing data of 57 pairs of GBC and paired adjacent cancer samples and found that the ErbB signaling pathway was the most significant pathway with mutation enrichment, and the aberration of ErbB signaling pathway was associated with worse survival of GBC patients.